IONS
USDIonis Pharmaceuticals Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$73.790
Kõrge
$75.000
Madal
$72.360
Maht
0.79M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
11.9B
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
2.47M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $110
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $100 to $110.
Piper Sandler Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $77
Piper Sandler analyst Allison Bratzel maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $70 to $77.
TD Cowen Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $99
TD Cowen analyst Yaron Werber maintains Ionis Pharmaceuticals with a Buy and raises the price target from $59 to $99.
Morgan Stanley Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $94
Morgan Stanley analyst Michael Ulz maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $90 to $94.
HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Raises Price Target to $100
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals with a Buy and raises the price target from $95 to $100.
Barclays Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $95
Barclays analyst Gena Wang maintains Ionis Pharmaceuticals with a Overweight and raises the price target from $80 to $95.
RBC Capital Maintains Outperform on Ionis Pharmaceuticals, Raises Price Target to $82
RBC Capital analyst Luca Issi maintains Ionis Pharmaceuticals with a Outperform and raises the price target from $80 to $82.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.